3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 28.65
-0.35 (-1.21%)
May 29, 2026, 1:35 PM CST
3D Global Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,267 | 3,760 | 5,131 | 1,088 | 1,498 | 2,143 | |
Market Cap Growth | -41.98% | -26.72% | 371.49% | -27.35% | -30.09% | -18.98% |
Enterprise Value | 1,839 | 3,076 | 4,797 | 915 | 1,295 | 1,901 |
Last Close Price | 29.45 | 48.30 | 66.14 | 19.00 | 26.32 | 38.77 |
PE Ratio | 35.06 | 56.51 | 55.95 | - | - | - |
PS Ratio | 10.97 | 18.19 | 19.31 | 52.74 | 109.79 | 193.46 |
PB Ratio | 2.30 | 3.82 | 5.67 | 3.71 | 4.40 | 5.50 |
P/TBV Ratio | 2.49 | 4.13 | 6.28 | 5.69 | 6.70 | 9.03 |
P/FCF Ratio | 21.64 | 35.90 | 344.12 | - | - | - |
P/OCF Ratio | 20.44 | 33.90 | 261.08 | - | - | - |
EV/Sales Ratio | 8.89 | 14.88 | 18.05 | 44.33 | 94.89 | 171.68 |
EV/EBITDA Ratio | 26.65 | 52.89 | 45.85 | - | - | - |
EV/EBIT Ratio | 44.35 | 74.20 | 54.20 | - | - | - |
EV/FCF Ratio | 17.55 | 29.37 | 321.70 | - | - | - |
Debt / Equity Ratio | 0.05 | 0.05 | 0.09 | 0.04 | 0.05 | 0.06 |
Debt / EBITDA Ratio | 0.71 | 0.71 | 0.77 | - | - | - |
Debt / FCF Ratio | 0.47 | 0.47 | 5.69 | - | - | - |
Net Debt / Equity Ratio | -0.43 | -0.43 | -0.68 | -0.53 | -0.56 | -0.54 |
Net Debt / EBITDA Ratio | -7.37 | -7.37 | -5.92 | 3.35 | 4.07 | 4.99 |
Net Debt / FCF Ratio | -4.09 | -4.09 | -41.52 | 4.81 | 5.43 | 5.45 |
Asset Turnover | 0.19 | 0.19 | 0.39 | 0.06 | 0.03 | 0.02 |
Inventory Turnover | 3.96 | 3.96 | 17.14 | 4.41 | 5.14 | 9.16 |
Quick Ratio | 13.49 | 13.49 | 15.75 | 6.34 | 10.41 | 15.71 |
Current Ratio | 14.08 | 14.08 | 15.93 | 6.63 | 10.71 | 16.04 |
Return on Equity (ROE) | 7.04% | 7.04% | 15.31% | -18.28% | -18.37% | -14.24% |
Return on Assets (ROA) | 2.44% | 2.44% | 8.12% | -11.30% | -10.41% | -8.57% |
Return on Invested Capital (ROIC) | 7.46% | 9.85% | 39.90% | -43.84% | -40.57% | -33.56% |
Return on Capital Employed (ROCE) | 3.90% | 3.90% | 9.00% | -21.10% | -18.90% | -15.20% |
Earnings Yield | 2.93% | 1.77% | 1.79% | -5.33% | -4.48% | -2.79% |
FCF Yield | 4.62% | 2.79% | 0.29% | -2.98% | -2.36% | -1.81% |
Dividend Yield | 0.34% | 0.21% | 0.80% | - | - | - |
Payout Ratio | 62.03% | 62.03% | - | - | - | - |
Buyback Yield / Dilution | -11.92% | -11.92% | -26.08% | -2.32% | -1.69% | -0.77% |
Total Shareholder Return | -11.58% | -11.71% | -25.27% | -2.32% | -1.69% | -0.77% |